10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,678 | -26.1% | 17,374 | +0.0% | 0.02% | -22.6% |
| Q2 2023 | $969,941 | +0.0% | 17,370 | -0.1% | 0.03% | -6.1% |
| Q1 2023 | $969,574 | +30.5% | 17,379 | -14.8% | 0.03% | +3.1% |
| Q4 2022 | $742,975 | +29.0% | 20,389 | +0.8% | 0.03% | +18.5% |
| Q3 2022 | $576,000 | -36.9% | 20,235 | +0.3% | 0.03% | -35.7% |
| Q2 2022 | $913,000 | -39.6% | 20,166 | -0.3% | 0.04% | -30.0% |
| Q1 2022 | $1,512,000 | +36.7% | 20,234 | +172.5% | 0.06% | +46.3% |
| Q4 2021 | $1,106,000 | +110500.0% | 7,424 | +74140.0% | 0.04% | – |
| Q3 2021 | $1,000 | -50.0% | 10 | -9.1% | 0.00% | – |
| Q2 2021 | $2,000 | -99.7% | 11 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $630,000 | +20900.0% | 3,480 | +19233.3% | 0.03% | – |
| Q4 2020 | $3,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |